Categories: HospitalsNews

Harrington Discovery Institute Opens Call for 2026 Harrington Scholar-Innovator Award

Unique program for physician-scientists to advance promising discoveries into medicines

CLEVELAND, April 16, 2025 /PRNewswire/ — Harrington Discovery Institute at University Hospitals is now accepting Letters of Intent for the 2026 Harrington Scholar-Innovator Award for physician-scientists. The award offers successful applicants multiple opportunities for funding in addition to expertise from pharma-experienced leaders with a track record of bringing drugs to market. Intellectual property rights are retained by the award recipient and/or their institution. Up to 12 Scholar-Innovators will be selected to receive:

  • $100,000 guaranteed grant award;
  • Drug and business development support from Harrington’s Therapeutics Development Center advisors;  
  • Opportunity to compete for acceleration funds up to $300,000;
  • Opportunity to qualify for investment funds typically up to $2M.

The call is open to physician-scientists at accredited academic medical centers, research institutions and universities in the United States and Canada. Applicants must have a doctorate in medicine. Selection criteria include innovation, creativity and the potential for clinical impact. Award recipients will be selected by Harrington Discovery Institute’s Scientific Advisory Board and announced in April 2026.

The deadline to submit a brief Letter of Intent is June 4, 2025. The full application deadline, for those invited to submit, is August 4, 2025.

Learn more and apply to the 2026 Scholar-Innovator Award:
HarringtonDiscovery.org/Scholar-Innovators

View original content:https://www.prnewswire.com/news-releases/harrington-discovery-institute-opens-call-for-2026-harrington-scholar-innovator-award-302429952.html

SOURCE Harrington Discovery Institute

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

17 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

17 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

2 days ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

2 days ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

2 days ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

2 days ago